Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 95 (3), 320-324
- https://doi.org/10.1111/1523-1747.ep12485060
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Proliferative Activity of Cutaneous Melanocytic Tumors Defined by Ki-67 Monoclonal AntibodyThe American Journal of Dermatopathology, 1989
- Immunohistologic Evidence for the Malignant Potential of Congenital Melanocytic NeviJournal of Investigative Dermatology, 1989
- Ki‐67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlationsThe Journal of Pathology, 1988
- Differential Expression of HLA-DR, DQ, and DP Antigens in Primary and Metastatic MelanomaJournal of Investigative Dermatology, 1988
- Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skinCancer, 1987
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.Journal of Clinical Pathology, 1986
- Phenotypic dynamics of tumor progression in human malignant melanomaInternational Journal of Cancer, 1985
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970